| View |
|
DR-XY28593
|
Propofol
|
Diprivan
|
10 mg/mL
|
Emulsion For Intravenous Injection
|
General Anesthetic
|
Corden Pharma S.P.A.
|
Italy
|
Automatic Renewal
|
23 February 2023
|
29 April 2028
|
| View |
|
DR-XY28601
|
Permethrin
|
Lindell
|
50mg/mL (5%)
|
Lotion
|
Scabicide/Pediculocide
|
Swiss Pharma Research Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 March 2023
|
06 May 2028
|
| View |
|
DR-XY28626
|
Pimecrolimus
|
Elidel
|
10mg/ g (1%)
|
Cream
|
-
|
MEDA Manufacturing
|
France
|
Automatic Renewal
|
16 April 2021
|
25 May 2026
|
| View |
|
DR-XY28639
|
Bleomycin (As Sulfate)
|
Bloicin-S
|
15 Units
|
Powder For Injection
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Korea United Pharm. Inc.
|
Korea
|
Automatic Renewal
|
13 March 2023
|
14 May 2028
|
| View |
|
DR-XY28641
|
Calcitriol
|
Rocaltrol
|
0.25 mcg
|
Soft-gelatin capsule
|
Vitamins
|
Catalent Germany Eberbach GmbH
|
Germany
|
Automatic Renewal
|
13 December 2022
|
12 May 2028
|
| View |
|
DR-XY28661
|
Tramadol Hydrochloride
|
Unbranded
|
50 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Opioid Analgesics
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Renewal
|
27 March 2023
|
21 May 2028
|
| View |
|
DR-XY28662
|
Tramadol Hydrochloride
|
None
|
50 mg/mL
|
Solution For Injection (I.M./I.V.)
|
Opioid Analgesic
|
Karnataka Antibiotics & Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
06 March 2023
|
21 May 2028
|
| View |
|
DR-XY28684
|
Metoclopramide (as hydrochloride)
|
Clozil
|
5mg/Ml (10mg/2mL)
|
Solution for Injection (IM/IV)
|
Gastrokinetic (Prokinetic)
|
Jinling Pharmaceutical Co., Ltd. Zhejiang Tianfeng Pharmaceutical Factory
|
China
|
Renewal
|
28 April 2022
|
26 October 2027
|
| View |
|
DR-XY28703
|
Sodium Bicarbonate
|
None
|
8.4% (1MEQ/mL)
|
Solution For Infusion (Iv)
|
Electrolyte
|
Atlantic Laboratories Corp. Ltd.
|
Thailand
|
Automatic Renewal
|
15 June 2023
|
12 June 2028
|
| View |
|
DR-XY28706
|
Calcipotriol (As Hydrate) + Betamethasone (As Dipropionate)
|
Daivobet
|
50 mcg / 500 mcg / gram
|
Ointment
|
Antipsoriatics
|
Leo Laboratories Ltd.
|
Ireland
|
Automatic Renewal
|
15 June 2023
|
12 June 2028
|
| View |
|
DR-XY28725
|
Isoniazid/ Pyridoxine Hydrochloride
|
Terozid Forte
|
200 mg/ 20 mg per 5 mL
|
Syrup
|
Antituberculosis
|
Drugmakers Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
13 March 2023
|
24 June 2028
|
| View |
|
DR-XY2873
|
Potassium Chloride
|
None
|
40 mEq / 20 mL
|
Solution For Injection
|
I.V. Solution additives (Electrolyte solutions)
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 August 2022
|
14 October 2027
|
| View |
|
DR-XY28738
|
Aciclovir
|
Virest
|
400 mg
|
Antiviral
|
Antiviral (Antiherpes Agent)
|
Hovid Berhad
|
Malaysia
|
Automatic Renewal
|
31 January 2023
|
04 July 2028
|
| View |
|
DR-XY28759
|
Ciprofloxacin
|
Cirok
|
2 mg/mL
|
Solution For IV Infusion
|
Antibacterial (Fluoroquinolone)
|
Korea United Pharm Inc.
|
Korea
|
Automatic Renewal
|
10 March 2023
|
09 July 2028
|
| View |
DR-XY28803_PI_01_NO RX SYMBOL.pdf
|
DR-XY28803
|
Brimonidine tartrate
|
Unbranded
|
1.5 mg/mL (0.15%)
|
Sterile Ophthamic Solution
|
Antiglaucoma Preparation and Miotic (Sympathomimetic in glaucoma therapy)
|
Allergan Pharmaceuticals Ireland
|
Ireland
|
Renewal
|
10 March 2024
|
21 July 2029
|
| View |
|
DR-XY28808
|
Valganciclovir (As Hydrochloride)
|
Valcyte
|
450 mg
|
Film Coated Tablet
|
Antiviral (Nucleosides and nucleotides excluding reverse transcriptase inhibitors)
|
Patheon Inc.
|
Canada
|
Automatic Renewal
|
27 October 2022
|
21 January 2028
|
| View |
|
DR-XY28817
|
Furosemide
|
Diuspec
|
40 mg
|
Tablet
|
Diuretic
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 June 2023
|
24 July 2028
|
| View |
|
DR-XY28822
|
Co-Amoxiclav
|
Claventin
|
625 mg
|
Tablet
|
Antibacterial (Penicillin)
|
Pt. Dankos Farma
|
Indonesia
|
Renewal
|
19 April 2024
|
28 July 2028
|
| View |
|
DR-XY28837
|
Prednisone
|
Prolix
|
10 mg/5 mL
|
Suspension
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 June 2023
|
28 July 2028
|
| View |
|
DR-XY28840
|
Fenofibrate
|
Lipway SR
|
250 mg
|
Sustained-Release Capsule
|
Lipid Modifying Agent (Fibrate)
|
SwissPharma Research Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
12 April 2023
|
29 July 2028
|